RLFTY — MindMaze Therapeutics Holding SA

—
OTC · Health Care · Pharmaceuticals · CIK 1854078 · Switzerland
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 44,107,000 5,324,000 8,176,000
Dec 2025 — — — — 51,530,000 9,473,000 13,189,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-17,384,000
Inventory
$896,000
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,196,000
EBITDA
$-10,215,000
Free Cash Flow
—
Enterprise Value
$66,522,360
Total Cash
$5,324,000
Total Debt
$24,000
Shares Out
169,993,750
Trailing EPS
$-0.30
Book Value
$0.31
ROE
-51.6%
ROA
-25.5%
Div Yield
—

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 642,000 -10,515,000 -9,906,000 51,530,000 13,189,000 38,341,000 -7,208,000
Dec 2024 0 -2,000 -1,000 93,000 7,000 86,000 -3,000

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.20T $1347.11 —
JNJ JOHNSON & JOHNSON $651.11B $270.47 —
ABBV AbbVie Inc. $505.89B $286.20 —
MRK Merck & Co., Inc. $329.65B $133.72 —
NVS NOVARTIS AG $286.00B $150.47 —

News headlines (Yahoo Finance, 1h cache)

MindMaze Therapeutics Announces CHF 4 Million Financing
2026-11-17 06:38 · Yahoo
MindMaze Therapeutics Reports New Home-Based Rehabilitation Results Ahead of MindMotion Lite Launch
2026-10-14 20:49 · Yahoo
OTC Markets Group Announces Third Annual Global Markets Forum Presentations Now Available On Demand
2026-10-12 12:35 · Yahoo
MindMaze Therapeutics expands digital neurorehabilitation platform across US and Global markets
2026-10-07 15:44 · Yahoo
OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th
2026-10-05 12:35 · Yahoo
MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation
2026-09-17 05:31 · Yahoo
MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update
2026-08-27 05:32 · Yahoo
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
2026-08-12 05:39 · Yahoo
MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
2026-08-10 05:28 · Yahoo
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.